Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-26 @ 12:25 AM
Study NCT ID:
NCT06141460
Status:
RECRUITING
Last Update Posted:
2024-11-14
First Post:
2023-11-10
Is Possible Gene Therapy:
True
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Sponsor:
Shanghai Refreshgene Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-10
First Submit QC Date:
None
Study First Post Date:
2023-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-12
Last Update Post Date:
2024-11-14
Last Update Post Date Type:
ACTUAL